A bispecific antibody inhibits FGFR3 dimerization and is highly effective in FGFR3-driven tumor models

被引：0
|
作者：
Yang, Yan
Avvaru, Naga Suhasini
Jiang, Zaoli
Liu, Nina
Rosconi, Michael
Zhang, Bojie
Li, Yinyin
Ullman, Erica
Lin, John Chia-Yang
Shen, Yang
Daly, Christopher
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B129
引用
收藏
页数：2
相关论文
共 50 条
  • [31] FGFR3 can predict tumor outcome in patients with superficial urothelial cancer
    Mhawech, P
    Herrmann, F
    Fischer, G
    Beck, A
    Cheney, RT
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (04) : 632 - 632
  • [32] Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301)
    Tran, B.
    Boni, A.
    Hansen, A.
    Boni, V.
    Mantia, C.
    Yu, E.
    Weickhardt, A.
    Robert, M.
    Gupta, S.
    Necchi, A.
    Morales-Barrera, R.
    Hoimes, C.
    Berlin, J.
    Iyer, G.
    Millward, M.
    Burn, T.
    Lihou, C.
    Gammon, G.
    Rosenberg, J.
    Loriot, Y.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S175 - S175
  • [33] Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
    Pouessel, D.
    Neuzillet, Y.
    Mertens, L. S.
    van der Heijden, M. S.
    de Jong, J.
    Sanders, J.
    Peters, D.
    Leroy, K.
    Manceau, A.
    Maille, P.
    Soyeux, P.
    Moktefi, A.
    Semprez, F.
    Vordos, D.
    de la Taille, A.
    Hurst, C. D.
    Tomlinson, D. C.
    Harnden, P.
    Bostrom, P. J.
    Mirtti, T.
    Horenblas, S.
    Loriot, Y.
    Houede, N.
    Chevreau, C.
    Beuzeboc, P.
    Shariat, S. F.
    Sagalowsky, A. I.
    Ashfaq, R.
    Burger, M.
    Jewett, M. A. S.
    Zlotta, A. R.
    Broeks, A.
    Bapat, B.
    Knowles, M. A.
    Lotan, Y.
    van der Kwast, T. H.
    Culine, S.
    Allory, Y.
    van Rhijn, B. W. G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1311 - 1316
  • [34] Generation and characterization of a monoclonal antibody against FGFR3 that protects mice from BoNT/A
    Xiong, Xianghua
    Qiu, Yujin
    Zheng, Jiahao
    Zhou, Ling
    Wang, Qingyang
    Pang, Jinglun
    Zhang, Weicai
    Chen, Huipeng
    Liu, Gang
    Han, Xiaodong
    PROTEIN EXPRESSION AND PURIFICATION, 2024, 213
  • [35] The development of multiple bladder tumor recurrences in relation to the FGFR3 mutation status of the primary tumor
    Kompier, Lucie
    van Tilborg, Angela
    van der Aa, Madelon
    Lurkin, Irene
    Vermeij, Marcel
    Kirkels, Wim
    Bangma, Chris
    van der Kwast, Theo
    Zwarthoff, Ellen
    CANCER RESEARCH, 2009, 69
  • [36] Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors
    Li, Gary
    Krook, Melanie
    Roychowdhury, Sameek
    Avogadri, Francesca
    Ye, Yining
    Moran, Susan
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Study of TERT promoter and FGFR3 mutations in upper-tumor urothelial carcinomas
    Mouawad, Roger
    Bensalma, Souheyla
    Su, Xiaoping
    Allanic, Frederick
    Comperat, Eva
    Roupret, Morgan
    Spano, JeanPhillipe
    Malouf, Gabriel
    Khayat, David
    CANCER RESEARCH, 2016, 76
  • [38] Tissue specific FGFR3 transgenic mouse models for Thanatophoric Dysplasia Type II
    Lin, T
    Sandusky, SB
    Xue, H
    Fishbein, K
    Spencer, R
    Rao, M
    Francomano, CA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 323 - 323
  • [39] FGF1 and FGF2 Induced FGFR3 Dimerization in Plasma Membrane Derived Vesicles
    Sarabipour, Sarvenaz
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 103A - 103A
  • [40] FGFR3 transmembrane domain dimerization in lipid bilayers: probing the energetics behind an autosomal dominant growth disorder
    Hristova, Kalina
    Li, Edwin
    Merzlyakov, Mikhail
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2006, 84 (06): : 1072 - 1072
12345